Wildcat Licensing v. Atlas Copco — Federal Circuit Affirms Patent Invalid After 743-Day Appeal
Wildcat Licensing, LLC asserted US Reissue Patent RE47,232 — covering multi-location fastening assembly monitoring systems — against Atlas Copco, Magna International, Faurecia Automotive Seating, and General Motors. The Federal Circuit affirmed the patent unpatentable, ending the appeal after 743 days.
Federal Circuit kills reissue patent targeting automotive assembly tech
Wildcat Licensing, LLC filed this appeal at the Court of Appeals for the Federal Circuit on 27 December 2021, challenging an earlier adverse ruling on US Reissue Patent RE47,232. The patent covers an assembly system for monitoring proper fastening of an article of assembly at more than one location — technology directly relevant to automotive manufacturing processes. Defendants included Atlas Copco Tools and Assembly Systems, Magna International, Faurecia Automotive Seating, and General Motors, an unusually broad coalition of automotive-sector participants.
The Federal Circuit closed the case on 9 January 2024, affirming the earlier finding of unpatentability. The basis of termination is recorded as ‘Unpatentable,’ meaning the appellate court upheld the conclusion that the patent’s claims do not meet the statutory requirements for patentability. For Wildcat Licensing, this forecloses further assertion of RE47,232 against any party. For the defendant coalition — spanning tooling suppliers, tier-one automotive suppliers, and an OEM — the decision removes the litigation risk attached to this specific patent entirely.
A 743-day appellate timeline is consistent with a contested patentability appeal at the Federal Circuit, which typically requires full briefing cycles and oral argument. The breadth of the defendant coalition — including General Motors and two major automotive suppliers — suggests the patent’s claimed scope was perceived as commercially threatening to assembly-line operations, which may have motivated a coordinated defence. The public record does not disclose whether any licensing negotiations occurred in parallel, nor the precise invalidity grounds upheld by the court.
Filing to settlement in 743 days
743-day Federal Circuit appeal duration
Federal Circuit affirms unpatentability of RE47,232 — what it means
What ‘affirmed unpatentable’ means at the Federal Circuit
An ‘affirmed’ ruling at the Federal Circuit means the appellate panel agreed with the lower tribunal’s conclusion — here, that the claims of US RE47,232 fail the requirements for patentability. This is a final appellate determination. Wildcat Licensing’s only remaining avenue would be an en banc petition or certiorari to the Supreme Court, both of which face very high bars. In practical terms, the patent is dead.
Final appellate rulingWhy reissue patents attract heightened invalidity scrutiny
US RE47,232 is a reissue patent, meaning the original claims were broadened or corrected post-grant. Reissue patents often face additional invalidity arguments, including recapture — where a patentee is barred from reclaiming scope surrendered during original prosecution. The Federal Circuit’s affirmance of unpatentability here is consistent with the heightened scrutiny that reissue claims typically attract, though the specific invalidity grounds are not disclosed in the public record.
Reissue patent doctrineCoalition defence: four defendants, one outcome
The presence of Atlas Copco, Magna International, Faurecia Automotive Seating, and General Motors as co-defendants suggests a coordinated invalidity challenge — a common strategy where accused infringers pool resources to attack patent validity rather than pursue individual licensing settlements. A successful validity challenge at the Federal Circuit benefits all defendants simultaneously and removes the patent as a future litigation tool against the broader industry.
Coordinated invalidity defenceAssembly monitoring freedom-to-operate restored for the sector
With RE47,232 affirmed unpatentable, manufacturers and tooling suppliers using multi-location fastening monitoring systems no longer face assertion risk from this specific patent. Companies in automotive assembly, industrial tooling, and quality-control systems that may have been tracking this litigation — or holding design-around contingencies — can treat this outcome as clearing one IP risk vector in the assembly monitoring space.
FTO cleared for sectorFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Wildcat Licensing, LLC | Company | Patent assertion entity — holder of US Reissue Patent RE47,232 on assembly monitoringSearch in Eureka ↗ |
| Defendant | Atlas Copco Tools and Assembly Systems, LLC | Company | Atlas Copco Tools and Assembly Systems LLC, with Magna International, Faurecia Automotive Seating, and General Motors as co-defendantsSearch in Eureka ↗ |
| Plaintiff counsel | Benjamin Cappel At | Attorney | Counsel for Wildcat Licensing, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Meredith Martin Addy | Attorney | Counsel for Wildcat Licensing, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Robert Patrick Hart | Attorney | Counsel for Wildcat Licensing, LLCSearch in Eureka ↗ |
| Defendant counsel | William Atkins | Attorney | Counsel for Atlas Copco Tools and Assembly Systems, LLCSearch in Eureka ↗ |
| Presiding judge | Judge / | Chief Judge | Court of Appeals for the Federal Circuit — Chief JudgeSearch in Eureka ↗ |
Stipulation of dismissal — official text
The single-word verdict ‘AFFIRMED’ in the context of an Invalidity/Cancellation Action means the Federal Circuit panel found no reversible error in the lower tribunal’s unpatentability determination against US RE47,232. This forecloses the patent as an enforceable asset. The affirmance applies to the claims as they stood on appeal; the public record does not specify whether all claims or a subset were at issue, which is a material detail for parties assessing residual risk from related Wildcat patents.
US RE47,232 — Multi-location fastening assembly monitoring system
US RE47,232 is a reissue of an earlier US patent, with the corrected application number recorded as US15/452306. The patent protects an assembly system for monitoring proper fastening of an article of assembly at more than one location — covering the verification that fasteners (such as bolts or screws) are correctly applied at multiple points in an assembly sequence. This technology is foundational to quality control in high-volume manufacturing, particularly in automotive body and powertrain assembly where multi-point torque verification is safety-critical. Reissue status indicates the original claims were amended post-grant, which itself became a focal point of the validity challenge.
The commercial significance of this patent class lies in the ubiquity of multi-location fastening verification in modern manufacturing lines. Atlas Copco is a leading global supplier of industrial fastening tools and assembly systems; its co-defendants Magna International and Faurecia are tier-one automotive suppliers whose assembly operations rely on precisely such monitoring technology. The Federal Circuit’s unpatentability affirmance suggests the claimed invention lacked sufficient novelty or non-obviousness to survive challenge — a signal that the broader space of assembly monitoring may be well prior-arted and difficult to ring-fence with broad reissue claims.
Should your team run an FTO against US RE47,232?
US RE47,232 has been affirmed unpatentable, which removes it as a direct infringement risk. However, R&D and product teams working on multi-location fastening monitoring, smart torque verification, or assembly quality control systems should not stop at this single patent. Wildcat Licensing may hold related patents or pending applications with overlapping claim scope. Any team commercialising assembly monitoring platforms — whether for automotive, aerospace, or industrial manufacturing — should verify the full landscape before treating this outcome as a complete clearance.
PatSnap Eureka’s FTO Search Agent can map the full claim landscape around multi-point fastening monitoring, identify patents related to or citing US RE47,232, and flag any live continuation or divisional applications that could represent residual risk. For companies that were named as defendants or operate in the same supply chain, setting up a claim monitoring alert against Wildcat Licensing’s portfolio is a low-cost step that provides early warning of any new assertion activity in the assembly monitoring space.
Run a freedom-to-operate analysis on USRE047232E to assess your product’s exposure
Run FTO in Eureka →Similar Federal Circuit patent invalidity cases in industrial assembly systems
PatSnap Eureka tracks related litigation across truck body equipment, vehicle accessories, and comparable infringement actions in the Georgia district system.
What this case signals for the assembly systems IP landscape
A Federal Circuit invalidity affirmance involving four major automotive-sector defendants carries implications beyond the parties named.
Reissue patents targeting automotive assembly remain high-risk assertions
This outcome reinforces the pattern that reissue patents asserted against established manufacturing defendants face coordinated, well-resourced invalidity challenges. Patent assertion entities targeting the automotive supply chain — particularly in process-monitoring and assembly technology — should expect coalition defence strategies and rigorous Federal Circuit scrutiny of reissue claim scope.
Coalition defendants can neutralise industry-wide patent threats efficiently
The joint defence by Atlas Copco, Magna, Faurecia, and General Motors illustrates how an OEM-supplier coalition can absorb appellate litigation cost while achieving a result that benefits the entire sector. Companies in similar positions — facing a common patent assertion across a supply chain — should evaluate whether a coordinated invalidity strategy delivers better risk/cost outcomes than individual licensing.
Wildcat v Atlas — key questions answered
The Federal Circuit affirmed the unpatentability of US Reissue Patent RE47,232 on 9 January 2024. The court upheld the lower tribunal’s invalidity finding, ending Wildcat Licensing’s appeal after 743 days. The patent can no longer be enforced.
US RE47,232 covers an assembly system for monitoring proper fastening of an article of assembly at more than one location — a technology central to automotive manufacturing quality control. It was asserted against Atlas Copco (fastening tools), Magna International, Faurecia Automotive Seating (tier-one suppliers), and General Motors, all of whom use multi-point fastening verification in their production processes.
A reissue patent is a corrected or broadened version of an original granted patent, re-examined and reissued by the USPTO. Reissue claims face additional invalidity challenges including the recapture doctrine, which bars patentees from reclaiming scope surrendered during original prosecution. This heightened scrutiny makes reissue patents more vulnerable to invalidity challenges, particularly when asserted with broad claim scope.
Defendants were Atlas Copco Tools and Assembly Systems LLC, Magna International Inc., Faurecia Automotive Seating LLC, and General Motors LLC. A coalition defence is common when a patent is asserted broadly across a supply chain — co-defendants pool resources to mount a single invalidity challenge that, if successful, eliminates the patent as a threat to the entire industry, not just individual parties.
No. The ruling applies solely to the specific claims of US RE47,232 that were before the court on appeal. Wildcat Licensing may hold other patents or pending applications in adjacent technology areas. Companies operating in assembly monitoring or fastening systems should conduct a full portfolio analysis of Wildcat Licensing’s IP holdings to assess any residual exposure.
PatSnap Eureka searches patents and litigation data to answer instantly.